Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round of $7M. The financing round was led by a group of US, Europe and Israel-based private investors; most of the investment comes from leading plastic surgeons and dermatologists. Hallura is a portfolio company of Alon Medtech Ventures owned by Dr. Shimon Eckhouse and is part of the Israeli Innovation Authority (IIA) incubator system.
Hallura’s HA Dermal Fillers are based on proprietary technology developed by the company over the last two years. Hallura developed a novel crosslinking technology answering the growing demand for natural and soft non-invasive aesthetic treatments.